RARE Debt-to-Equity Ratio Analysis
Higher than 0% of Healthcare sector peers
Updated 2555h ago·SEC filings & market data
Key Takeaway
A debt-to-equity ratio compares a company’s total liabilities to its shareholders’ equity; a negative value like -5.08x means Ultragenyx has more debt than the book value of its equity, effectively indicating negative equity on the balance sheet.
Sector Performance
0th percentileRARE
-5.08x
Sector Median
0.26x
Sector Avg
0.89x
Deep Analysis
A debt-to-equity ratio compares a company’s total liabilities to its shareholders’ equity; a negative value like -5.08x means Ultragenyx has more debt than the book value of its equity, effectively indicating negative equity on the balance sheet.
This places the company at the 0th percentile among healthcare peers, far below the sector median of 0.45x, where most competitors use moderate leverage. Trend data is not available—year-over-year and quarter-over-quarter changes are both marked as N/A, and the last eight quarters show no historical progression to evaluate. The combination of an extremely negative ratio and no trend history signals that the company is in a highly distressed capital structure, which raises substantial risk of financial instability or even insolvency. This metric directly supports the cautious overall verdict, as a negative equity position is a clear red flag for investors and contradicts any bullish outlook.
Frequently Asked Questions
What does the Debt-to-Equity Ratio tell investors about RARE?
Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.
How is the Debt-to-Equity Ratio calculated?
Debt-to-Equity Ratio is calculated as: Total Debt / Shareholders' Equity.
How does RARE's Debt-to-Equity Ratio compare to its sector?
RARE's Debt-to-Equity Ratio of -5.08x compares to a Healthcare sector median of 0.26x, placing it in the 0th percentile.
Who are RARE's closest peers by Debt-to-Equity Ratio?
The closest Healthcare peers by Debt-to-Equity Ratio include: BIO (0.17x), BIIB (0.34x), NTLA (0.13x), TECH (0.10x), BEAM (0.09x).
Learn More About Debt-to-Equity Ratio
How to Spot a Debt Problem Before It Hits the Stock Price
Learn how to spot a debt problem in stocks using D/E, interest coverage, and net debt/EBITDA ratios. Real examples from META and MSFT, plus danger thresholds you need to know.
Debt/Equity Ratio: How Much Debt Is Too Much?
The debt to equity ratio explained: why context, interest coverage, and sector norms matter far more than the raw number when assessing debt risk.
The Formula
Total Debt / Shareholders' Equity
Why It Matters
Shows how much a company is financing its operations through debt vs shareholder funds. High D/E can amplify returns — and losses.
Master RARE's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full RARE research report →RARE
-5.08x
Sector Median
0.26x
Sector Avg
0.89x
How RARE's Debt-to-Equity Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.